Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4045193rdf:typepubmed:Citationlld:pubmed
pubmed-article:4045193lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:4045193lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:4045193lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:4045193lifeskim:mentionsumls-concept:C0074810lld:lifeskim
pubmed-article:4045193pubmed:issue5lld:pubmed
pubmed-article:4045193pubmed:dateCreated1985-11-21lld:pubmed
pubmed-article:4045193pubmed:abstractTextSoluble immune response suppressor (SIRS) isolated from the T cell hybrid 393D2.6 was originally reported to exist as at least two m.w. forms and to migrate on reverse-phase high-performance liquid chromatography columns as three separate species. In experiments presented here, a further analysis of the different chromatographic forms of SIRS has been carried out. SIRS-alpha elutes from C-18 reverse-phase columns in 20% propanol. When SIRS-alpha is subjected to isoelectric focusing, three biologically active species are isolated at approximately pH7, approximately pH6, and approximately pH5 (SIRS-alpha 7, SIRS-alpha 6, and SIRS-alpha 5, respectively). SIRS-beta elutes in 30% propanol, and on isoelectric focusing the biologic activity is found only at approximately pH7 (SIRS-beta 7). Both the alpha and beta forms of SIRS have nearly identical m.w. when subjected to molecular sieve chromatography and migrate with a m.w. of 11,000. The molecular basis for these isoforms is not yet clear but is consistent with earlier studies showing two separate messenger RNA species coding for SIRS.lld:pubmed
pubmed-article:4045193pubmed:languageenglld:pubmed
pubmed-article:4045193pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4045193pubmed:citationSubsetAIMlld:pubmed
pubmed-article:4045193pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4045193pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4045193pubmed:statusMEDLINElld:pubmed
pubmed-article:4045193pubmed:monthNovlld:pubmed
pubmed-article:4045193pubmed:issn0022-1767lld:pubmed
pubmed-article:4045193pubmed:authorpubmed-author:PierceC WCWlld:pubmed
pubmed-article:4045193pubmed:authorpubmed-author:MasonKKlld:pubmed
pubmed-article:4045193pubmed:authorpubmed-author:WebbD RDRlld:pubmed
pubmed-article:4045193pubmed:authorpubmed-author:AuneT MTMlld:pubmed
pubmed-article:4045193pubmed:authorpubmed-author:SemenukGGlld:pubmed
pubmed-article:4045193pubmed:issnTypePrintlld:pubmed
pubmed-article:4045193pubmed:volume135lld:pubmed
pubmed-article:4045193pubmed:ownerNLMlld:pubmed
pubmed-article:4045193pubmed:authorsCompleteYlld:pubmed
pubmed-article:4045193pubmed:pagination3238-42lld:pubmed
pubmed-article:4045193pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:meshHeadingpubmed-meshheading:4045193-...lld:pubmed
pubmed-article:4045193pubmed:year1985lld:pubmed
pubmed-article:4045193pubmed:articleTitlePurification and analysis of isoforms of soluble immune response suppressor (SIRS).lld:pubmed
pubmed-article:4045193pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:4045193pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:4045193pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4045193lld:pubmed